Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroko Hachiken is active.

Publication


Featured researches published by Hiroko Hachiken.


Tetrahedron Letters | 1996

Reaction of indole-2,3-dicarboxylic anhydride with (3-bromo-4-pyridyl)triisopropoxytitanium: Synthesis of ellipticine

Yasuyoshi Miki; Yoshitaka Tada; Norihide Yanase; Hiroko Hachiken; Ko-ichi Matsushita

Abstract N -Benzylindole-2,3-dicarboxylic anhydride ( 1 ) was reacted with (3-bromo-4-pyridyl)triisopropoxytitanium to give 2-(3-bromoisonicotinoyl)indole-3-carboxylic acid ( 2 ) as the sole product in high yield, which could be converted to ellipticine in six steps.


Journal of The Chemical Society-perkin Transactions 1 | 2001

Synthesis of ellipticine by reaction of 1-(4-methoxybenzyl)indole-2,3-dicarboxylic anhydride with (3-bromo-4-pyridyl)triisopropoxytitanium

Yasuyoshi Miki; Hiroko Hachiken; Norihide Yanase

Reaction of 1-benzyl- and 1-(4-methoxybenzyl)indole-2,3-dicarboxylic anhydride with (3-bromo-4-pyridyl)triisopropoxytitanium gave the corresponding 2-acylindole-3-carboxylic acids as the sole product. Deprotection of the 1-(4-methoxybenzyl) group of the 2-acylindole-3-carboxylic acid was performed by treatment with perchloric acid in acetic acid to afford 2-(3-bromoisonicotinoyl)indole, which was converted to ellipticine.


Heterocycles | 1994

Synthesis of 3-Substituted Pyrazolo[1,5-a]pyridines by Electrophilic Reactions

Yasuyoshi Miki; Sanae Yagi; Hiroko Hachiken; Masazumi Ikeda

Reactions of pyrazolo[1,5-a]pyridines with Eschenmosers salt, activa- ted alkenes and alkynes, and chlorosulfonyl isocyanate provided general routes to 3-substituted pyrazolo[1,5-a]pyridines such as 3-dimethylami- nomethyl-and 3-(2-nitroethyl)pyrazolo[1,5-a]pyridines, 1-phenyl-3-(py- razolo[1,5-a]pyrid-3-yl)-2-propen-1-ones, 4-(pyrazolo[1,5-a]pyrid-3-yl) -3-buten-2-one, pyrazolo[1,5-a]pyridine-3-carboxamide, and pyrazolo [1,5-a]pyridine-3-carbonitrile


Heterocycles | 1991

A new entry to [2.3.4]cyclazines

Yasuyoshi Miki; Hiroko Hachiken; Masayuki Yoshikawa; Shoji Takemura; M. Ikeda

Treatment of 2,3-dihydro-2-methyl-3-phenyl-1H- pyrazino 3,4,5-cd indolizine 2-oxides (5) with trifluoroacetic anhydride gave new heterocyclic six-membered betaines (6) which underwent 1,3-dipolar cycloaddition reaction with dimethyl acetylenedicarboxylate and maleimides in hot toluene to yield the corresponding cycloadducts (7) and (8). Treatment of the maleimide adducts (8) with p-toluenesulfonic acid in boiling acetic acid gave the [2.3.4]cyclazines (9)


principles and practice of constraint programming | 2013

Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.

Hiroko Hachiken; Ai Murai; Kyoichi Wada; Takeshi Kuwahara; Kouichi Hosomi; Mitsutaka Takada

OBJECTIVE To provide further insights on the risks of gastrointestinal (GI) complications in individuals using low-dose aspirin (LDA), we investigated the concomitant use of LDA and antisecretory drugs. Additionally, we examined the frequency distributions of prescribing sequences for LDA and antisecretory drugs. METHODS Data from a computerized prescription order entry system was analyzed at the National Cerebral and Cardiovascular Center of Japan. LDA use in combination with H2-receptor antagonists (H2RAs) and proton pomp inhibitors (PPIs) was examined over the period from January 2001 to December 2010. Prescription sequence symmetry analyses were used to identify LDA-induced H2RAs or PPIs users. RESULTS In December 2010, PPIs accounted for 9.9% of the prescriptions for buffered LDA users and 16.1% of those for enteric-coated LDA users. Incident use of PPIs occurred more frequently among enteric-coated LDA users than buffered LDA users (17.6% vs. 11.0%, respectively). Prescription sequence symmetry analyses of PPI use revealed significant associations with enteric-coated LDA use, resulting in adjusted sequence ratios of 1.82 (95%CI, 1.11 - 3.03) and 1.87 (95% CI, 1.26 - 2.83) at intervals of 182 and 365 days, respectively. Enteric-coated LDA users tended to initiate PPI therapy on the same date more frequently than buffered LDA users (35.1% vs. 10.8%, respectively). CONCLUSIONS Our findings do not support the notion that entericcoated LDA products confer a lower risk for GI complications than buffered formulations, but may conversely imply that the risk of GI complications associated with buffered LDA is lower than that of enteric-coated LDA.


Heterocycles | 2002

Synthesis of 2- and 3-Benzoylindoles by Friedel-Crafts Reaction of Indole-2,3-dicarboxylic Anhydrides with Anisoles

Yasuyoshi Miki; Yasuhiko Tsuzaki; Chika Kai; Hiroko Hachiken

Reaction of 1-benzylindole-2,3-dicarboxylic anhydride with anisole in the presence of titanium(IV) chloride gave 2-(4-methoxybenzoyl)indole-3-carboxylic acid as the sole product. However, l-benzenesulfonylindole-2,3-dicarboxylic anhydride with anisole afforded 3-(4-methoxybenzoyl)indole-2-carboxylic acid. These carboxylic acids could be converted to the corresponding benzoylindoles.


Synlett | 1993

Synthesis and Diels-Alder reaction of 4-benzyl-1-tert-butyldimethylsiloxy-4H-furo[3,4-b]indole : synthesis of murrayaquinone-A

Yasuyoshi Miki; Hiroko Hachiken


Heterocycles | 1984

Novel synthesis and 1,3-dipolar cycloaddition reaction of pyridinium N-methylide

Yasuyoshi Miki; Hiroko Hachiken; Shoji Takemura; Masazumi Ikeda


Heterocycles | 1998

p-methoxybenzyl group as a protecting group of the nitrogen in indole derivatives: deprotection by DDQ or trifluoroacetic acid

Yasuyoshi Miki; Hiroko Hachiken; Yoshimi Kashima; Wakiko Sugimura; Norihide Yanase


Heterocycles | 1997

Reaction of Indole-2,3-dicarboxylic Anhydride with Grignard Reagents: Synthesis of 2-Acylindoles

Yasuyoshi Miki; Hiroko Hachiken; Ichigo Yoshikawa

Collaboration


Dive into the Hiroko Hachiken's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge